With an attrition rate of up to 95% for oncology drug development, it is evident that significant barriers still exist when it comes to translating preclinical investigation findings to in-human trials.
Our guide explores how humanized mouse models can help accelerate the successful development of novel, safe, and effective treatments for oncology by generating human-relevant data.
We examine:
Brought to you by